Seeking AlphaazioniBULLISHLOW

Alnylam Pharmaceuticals Non-GAAP EPS of $16.26 beats by $14.01, revenue of $1.46B beats by $30M

No summary available

Read at Seeking Alpha
Alnylam Pharmaceuticals Non-GAAP EPS of $16.26 beats by $14.01, revenue of $1.46B beats by $30M